Highlights
NASDAQ: BMRN       Biomarin Pharmaceut
Last Price Today's Change   Day's Range   Trading Volume
92.49   +4.21 (4.77%)  90.27 - 92.87  3,443,900

Overview

 
Avg Volume (4 weeks):1,464,047
4 Weeks Range:81.52 - 92.87
4 Weeks Price Volatility (%):
96.65%
52 Weeks Range:75.81 - 100.03
52 Weeks Price Volatility (%):
68.87%
Average Price Target: 133.00
Price Target Upside/Downside: +40.51

Headlines



No recent Headlines for this stock.


Business Background

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

  Be the first to like this.
 


 

3996  3494  969  99 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NVCN 0.04-0.005 
 CHK 4.30-0.25 
 SPY 272.15-0.65 
 MU 61.35-0.14 
 GE 14.63+0.03 
 PBR 12.61-0.17 
 GDX 22.31-0.34 
 BAC 30.16-0.05 
 AMD 13.54+0.13 
 USO 13.68-0.61 
Partners & Brokers